Dimethylcysteine en es it fr

Dimethylcysteine Brand names, Dimethylcysteine Analogs

Dimethylcysteine Brand Names Mixture

  • No information avaliable

Dimethylcysteine Chemical_Formula


Dimethylcysteine RX_link


Dimethylcysteine fda sheet

Dimethylcysteine FDA

Dimethylcysteine msds (material safety sheet)

Dimethylcysteine MSDS

Dimethylcysteine Synthesis Reference

No information avaliable

Dimethylcysteine Molecular Weight

149.212 g/mol

Dimethylcysteine Melting Point

198.5 oC

Dimethylcysteine H2O Solubility

1.11E+005 mg/L

Dimethylcysteine State


Dimethylcysteine LogP


Dimethylcysteine Dosage Forms

Capsule; Tablet

Dimethylcysteine Indication

For treatment of Wilson's disease, cystinuria and active rheumatoid arthritis

Dimethylcysteine Pharmacology

Penicillamine is a chelating agent used in the treatment of Wilson's disease. It is also used to reduce cystine excretion in cystinuria and to treat patients with severe, active rheumatoid arthritis unresponsive to conventional therapy. Penicillamine is used as a form of immunosuppression to treat rheumatoid arthritis. It works by reducing numbers of T-lymphocytes, inhibiting macrophage function, decreasing IL-1, decreasing rheumatoid factor, and preventing collagen from cross-linking. Its use in Wilson's disease, a rare genetic disorder of copper metabolism, relies on its binding to accumulated copper and elimination through urine.

Dimethylcysteine Absorption

rapidly but incompletely

Dimethylcysteine side effects and Toxicity

No information avaliable

Dimethylcysteine Patient Information

No information avaliable

Dimethylcysteine Organisms Affected

Humans and other mammals